HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

A study led by Harvard Medical School, explored the reason that causes the rise of aortic aneurysms, thus offering vital ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...

Israeli PM Benjamin Netanyahu praises US President Donald Trump for striking Iran's nuclear facilities, foreseeing a future ...

India pledges to evacuate Sri Lankan nationals from Iran during the Israel conflict, reinforcing Indo-Sri Lankan ties.